CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)
 
     
 
 
 
Cardium Therapeutics Incorporation Company Snapshot
Business Description:
Cardium Therapeutics Incorporation operates in the Biological products exc. diagnostic sector. Cardium Therapeutics, Inc. (Cardium) is a development-stage company. Cardium's business is focused on the acquisition and strategic development of product opportunities or businesses having the potential to address unmet medical needs. In November 2010, the Company announced the launch of its MedPodiumTM healthy lifestyle product platform and Web boutique. With additional products and distribution channels, the Company plans to develop MedPodium into a portfolio of science-based, easy to use medicinals, neurologics, metabolics, nutraceuticals and aesthetics intended to promote and manage personal health. In November 2010, the Company launched MedPodium, which is a healthy lifestyle product line and Web boutique. In our complete report available for purchase the company is compared to: Novavax, Inc., Neuralstem, Incorporation. and Genta Inc.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Cardium Therapeutics Incorporation
  Stock Performance Chart for Cardium Therapeutics Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (2/10/2012): .37
(Figures in U.S. Dollars)
1 Week -1.4%   13 Weeks 4.1%  
4 Weeks -19.7%   52 Weeks -5.1%  
 
Cardium Therapeutics Incorporation Key Data:
  Ticker: CXM Country: UNITED STATES
  Exchanges: ASE Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Medical, Surgical & Dental Suppliers
  2010 Sales 244,479
(Year Ending Jan 2011).
Employees: 15
  Currency: U.S. Dollars Market Cap: 34,372,398
  Fiscal Yr Ends: December Shares Outstanding: 92,898,373
  Share Type: Common Closely Held Shares: 7,615,160
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.